Synaptic functions of endocannabinoid signaling in health and disease

Neuropharmacology

Volumn 124, Issue , 2017, Pages 13-24

  Araque, Alfonso ^a   Castillo, Pablo E ^b   Manzoni, Olivier J ^c   Tonini, Raffaella ^d  

^a UNIVERSITY OF MINNESOTA   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c Turing Center for Living Systems CENTURI Aix Marseille University   (France)

^d ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

Author keywords

Astrocytes; Endocannabinoids; Hippocampus; Prefrontal cortex; Striatum; Synaptic plasticity

Indexed keywords

CANNABINOID 1 RECEPTOR; ENDOCANNABINOID;

ASTROCYTE; CORPUS STRIATUM; DORSAL STRIATUM; HIPPOCAMPUS; HUMAN; LONG TERM POTENTIATION; NEOCORTEX; NERVE CELL PLASTICITY; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SYNAPSE; ANIMAL; BRAIN; BRAIN DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; SYNAPTIC TRANSMISSION;

ANIMALS; BRAIN; BRAIN DISEASES; ENDOCANNABINOIDS; HUMANS; NEURONAL PLASTICITY; SYNAPTIC TRANSMISSION;

EID: 85021183652     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2017.06.017     Document Type: Review

References (185)

1. Abush, H., Akirav, I., Cannabinoids ameliorate impairments induced by chronic stress to synaptic plasticity and short-term memory. Neuropsychopharmacology 38 (2013), 1521–1534.
2. Adermark, L., Lovinger, D.M., Combined activation of L-type Ca2+ channels and synaptic transmission is sufficient to induce striatal long-term depression. J. Neurosci. 27 (2007), 6781–6787.
3. Adermark, L., Talani, G., Lovinger, D.M., Endocannabinoid-dependent plasticity at GABAergic and glutamatergic synapses in the striatum is regulated by synaptic activity. Eur. J. Neurosci. 29 (2009), 32–41.
4. Ahn, K., McKinney, M.K., Cravatt, B.F., Enzymatic pathways that regulate endocannabinoid signaling in the nervous system. Chem. Rev. 108 (2008), 1687–1707.
5. Andrade-Talavera, Y., Duque-Feria, P., Paulsen, O., Rodriguez-Moreno, A., Presynaptic spike timing-dependent long-term depression in the mouse Hippocampus. Cereb. Cortex 26 (2016), 3637–3654.
6. Araque, A., Carmignoto, G., Haydon, P.G., Oliet, S.H., Robitaille, R., Volterra, A., Gliotransmitters travel in time and space. Neuron 81 (2014), 728–739.
7. Araque, A., Parpura, V., Sanzgiri, R.P., Haydon, P.G., Tripartite synapses: glia, the unacknowledged partner. Trends Neurosci. 22 (1999), 208–215.
8. Bacci, A., Huguenard, J.R., Prince, D.A., Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids. Nature 431 (2004), 312–316.
9. Bagetta, V., Picconi, B., Marinucci, S., Sgobio, C., Pendolino, V., Ghiglieri, V., Fusco, F.R., Giampa, C., Calabresi, P., Dopamine-dependent long-term depression is expressed in striatal spiny neurons of both direct and indirect pathways: implications for Parkinson's disease. J. Neurosci. 31 (2011), 12513–12522.
10. Basu, J., Srinivas, K.V., Cheung, S.K., Taniguchi, H., Huang, Z.J., Siegelbaum, S.A., A cortico-hippocampal learning rule shapes inhibitory microcircuit activity to enhance hippocampal information flow. Neuron 79 (2013), 1208–1221.
11. Bateup, H.S., Santini, E., Shen, W., Birnbaum, S., Valjent, E., Surmeier, D.J., Fisone, G., Nestler, E.J., Greengard, P., Distinct subclasses of medium spiny neurons differentially regulate striatal motor behaviors. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 14845–14850.
12. Benard, G., Massa, F., Puente, N., Lourenco, J., Bellocchio, L., Soria-Gomez, E., Matias, I., Delamarre, A., Metna-Laurent, M., Cannich, A., Hebert-Chatelain, E., Mulle, C., Ortega-Gutierrez, S., Martin-Fontecha, M., Klugmann, M., Guggenhuber, S., Lutz, B., Gertsch, J., Chaouloff, F., Lopez-Rodriguez, M.L., Grandes, P., Rossignol, R., Marsicano, G., Mitochondrial CB(1) receptors regulate neuronal energy metabolism. Nat. Neurosci. 15 (2012), 558–564.
13. Best, A.R., Regehr, W.G., Serotonin evokes endocannabinoid release and retrogradely suppresses excitatory synapses. J. Neurosci. 28 (2008), 6508–6515.
14. Bortolato, M., Mangieri, R.A., Fu, J., Kim, J.H., Arguello, O., Duranti, A., Tontini, A., Mor, M., Tarzia, G., Piomelli, D., Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress. Biol. Psychiatry 62 (2007), 1103–1110.
15. Bosch-Bouju, C., Larrieu, T., Linders, L., Manzoni, O.J., Laye, S., Endocannabinoid-mediated plasticity in nucleus accumbens controls vulnerability to anxiety after social defeat stress. Cell Rep. 16 (2016), 1237–1242.
16. Burgos, H., Cofre, C., Hernandez, A., Saez-Briones, P., Agurto, R., Castillo, A., Morales, B., Zeise, M.L., Methylphenidate has long-lasting metaplastic effects in the prefrontal cortex of adolescent rats. Behav. Brain Res. 291 (2015), 112–117.
17. Busquets-Garcia, A., Gomis-Gonzalez, M., Guegan, T., Agustin-Pavon, C., Pastor, A., Mato, S., Perez-Samartin, A., Matute, C., de la Torre, R., Dierssen, M., Maldonado, R., Ozaita, A., Targeting the endocannabinoid system in the treatment of fragile X syndrome. Nat. Med. 19 (2013), 603–607.
18. Bystrowska, B., Smaga, I., Frankowska, M., Filip, M., Changes in endocannabinoid and N-acylethanolamine levels in rat brain structures following cocaine self-administration and extinction training. Prog. Neuropsychopharmacol. Biol. Psychiatry 50 (2014), 1–10.
19. Cachope, R., Mackie, K., Triller, A., O'Brien, J., Pereda, A.E., Potentiation of electrical and chemical synaptic transmission mediated by endocannabinoids. Neuron 56 (2007), 1034–1047.
20. Campos, A.C., Ferreira, F.R., da Silva, W.A. Jr., Guimaraes, F.S., Predator threat stress promotes long lasting anxiety-like behaviors and modulates synaptophysin and CB1 receptors expression in brain areas associated with PTSD symptoms. Neurosci. Lett. 533 (2013), 34–38.
21. Caporale, N., Dan, Y., Spike timing-dependent plasticity: a Hebbian learning rule. Annu. Rev. Neurosci. 31 (2008), 25–46.
22. Carlson, G., Wang, Y., Alger, B.E., Endocannabinoids facilitate the induction of LTP in the hippocampus. Nat. Neurosci. 5 (2002), 723–724.
23. Casadio, P., Fernandes, C., Murray, R.M., Di Forti, M., Cannabis use in young people: the risk for schizophrenia. Neurosci. Biobehav Rev. 35 (2011), 1779–1787.
24. Castillo, P.E., Younts, T.J., Chavez, A.E., Hashimotodani, Y., Endocannabinoid signaling and synaptic function. Neuron 76 (2012), 70–81.
25. Ceccarini, J., Hompes, T., Verhaeghen, A., Casteels, C., Peuskens, H., Bormans, G., Claes, S., Van Laere, K., Changes in cerebral CB1 receptor availability after acute and chronic alcohol abuse and monitored abstinence. J. Neurosci. 34 (2014), 2822–2831.
26. Cerovic, M., d'Isa, R., Tonini, R., Brambilla, R., Molecular and cellular mechanisms of dopamine-mediated behavioral plasticity in the striatum. Neurobiol. Learn Mem. 105 (2013), 63–80.
27. Chavez, A.E., Chiu, C.Q., Castillo, P.E., TRPV1 activation by endogenous anandamide triggers postsynaptic long-term depression in dentate gyrus. Nat. Neurosci. 13 (2010), 1511–1518.
28. Chevaleyre, V., Castillo, P.E., Heterosynaptic LTD of hippocampal GABAergic synapses: a novel role of endocannabinoids in regulating excitability. Neuron 38 (2003), 461–472.
29. Chevaleyre, V., Castillo, P.E., Endocannabinoid-mediated metaplasticity in the hippocampus. Neuron 43 (2004), 871–881.
30. Chiu, C.Q., Castillo, P.E., Input-specific plasticity at excitatory synapses mediated by endocannabinoids in the dentate gyrus. Neuropharmacology 54 (2008), 68–78.
31. Chiu, C.Q., Puente, N., Grandes, P., Castillo, P.E., Dopaminergic modulation of endocannabinoid-mediated plasticity at GABAergic synapses in the prefrontal cortex. J. Neurosci. 30 (2010), 7236–7248.
32. Cippitelli, A., Astarita, G., Duranti, A., Caprioli, G., Ubaldi, M., Stopponi, S., Kallupi, M., Sagratini, G., Rodriguez de Fonseca, F., Piomelli, D., Ciccocioppo, R., Endocannabinoid regulation of acute and protracted nicotine withdrawal: effect of FAAH inhibition. PLoS One, 6, 2011, e28142.
33. Cornish, K.M., Li, L., Kogan, C.S., Jacquemont, S., Turk, J., Dalton, A., Hagerman, R.J., Hagerman, P.J., Age-dependent cognitive changes in carriers of the fragile X syndrome. Cortex 44 (2008), 628–636.
34. Covelo, A., Araque, A., Lateral regulation of synaptic transmission by astrocytes. Neuroscience 323 (2016), 62–66.
35. Cui, G., Jun, S.B., Jin, X., Pham, M.D., Vogel, S.S., Lovinger, D.M., Costa, R.M., Concurrent activation of striatal direct and indirect pathways during action initiation. Nature 494 (2013), 238–242.
36. Cui, Y., Paille, V., Xu, H., Genet, S., Delord, B., Fino, E., Berry, H., Venance, L., Endocannabinoids mediate bidirectional striatal spike-timing-dependent plasticity. J. Physiol. 593 (2015), 2833–2849.
37. Cui, Y., Prokin, I., Xu, H., Delord, B., Genet, S., Venance, L., Berry, H., Endocannabinoid dynamics gate spike-timing dependent depression and potentiation. Elife, 5, 2016, e13185.
38. D'Souza, D.C., Abi-Saab, W.M., Madonick, S., Forselius-Bielen, K., Doersch, A., Braley, G., Gueorguieva, R., Cooper, T.B., Krystal, J.H., Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction. Biol. Psychiatry 57 (2005), 594–608.
39. den Boon, F.S., Chameau, P., Schaafsma-Zhao, Q., van Aken, W., Bari, M., Oddi, S., Kruse, C.G., Maccarrone, M., Wadman, W.J., Werkman, T.R., Excitability of prefrontal cortical pyramidal neurons is modulated by activation of intracellular type-2 cannabinoid receptors. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), 3534–3539.
40. Depoy, L., Daut, R., Brigman, J.L., Macpherson, K., Crowley, N., Gunduz-Cinar, O., Pickens, C.L., Cinar, R., Saksida, L.M., Kunos, G., Lovinger, D.M., Bussey, T.J., Camp, M.C., Holmes, A., Chronic alcohol produces neuroadaptations to prime dorsal striatal learning. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 14783–14788.
41. DePoy, L., Daut, R., Wright, T., Camp, M., Crowley, N., Noronha, B., Lovinger, D., Holmes, A., Chronic alcohol alters rewarded behaviors and striatal plasticity. Addict. Biol. 20 (2015), 345–348.
42. Di Marzo, V., The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation. Pharmacol. Res. Official J. Italian Pharmacol. Soc. 60 (2009), 77–84.
43. Dinh, T.P., Carpenter, D., Leslie, F.M., Freund, T.F., Katona, I., Sensi, S.L., Kathuria, S., Piomelli, D., Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc. Natl. Acad. Sci. U. S. A. 99 (2002), 10819–10824.
44. Dudman, J.T., Tsay, D., Siegelbaum, S.A., A role for synaptic inputs at distal dendrites: instructive signals for hippocampal long-term plasticity. Neuron 56 (2007), 866–879.
45. Egertová, M., Elphick, M.R., Localisation of cannabinoid receptors in the rat brain using antibodies to the intracellular C-terminal tail of CB. J. Comp. Neurol. 422 (2000), 159–171.
46. Eggan, S.M., Mizoguchi, Y., Stoyak, S.R., Lewis, D.A., Development of cannabinoid 1 receptor protein and messenger RNA in monkey dorsolateral prefrontal cortex. Cereb. Cortex 20 (2010), 1164–1174.
47. Fellin, T., Pascual, O., Gobbo, S., Pozzan, T., Haydon, P.G., Carmignoto, G., Neuronal synchrony mediated by astrocytic glutamate through activation of extrasynaptic NMDA receptors. Neuron 43 (2004), 729–743.
48. Fino, E., Paille, V., Cui, Y., Morera-Herreras, T., Deniau, J.M., Venance, L., Distinct coincidence detectors govern the corticostriatal spike timing-dependent plasticity. J. Physiol. 588 (2010), 3045–3062.
49. Foldy, C., Malenka, R.C., Sudhof, T.C., Autism-associated neuroligin-3 mutations commonly disrupt tonic endocannabinoid signaling. Neuron 78 (2013), 498–509.
50. Fortin, D.A., Levine, E.S., Differential effects of endocannabinoids on glutamatergic and GABAergic inputs to layer 5 pyramidal neurons. Cereb. Cortex 17 (2007), 163–174.
51. Foti, D.J., Kotov, R., Guey, L.T., Bromet, E.J., Cannabis use and the course of schizophrenia: 10-year follow-up after first hospitalization. Am. J. Psychiatry 167 (2010), 987–993.
52. Fourgeaud, L., Mato, S., Bouchet, D., Hemar, A., Worley, P.F., Manzoni, O.J., A single in vivo exposure to cocaine abolishes endocannabinoid-mediated long-term depression in the nucleus accumbens. J. Neurosci. 24 (2004), 6939–6945.
53. Francis, T.C., Lobo, M.K., Emerging role for nucleus accumbens medium spiny neuron subtypes in depression. Biol. Psychiatry 81 (2017), 645–653.
54. Freiman, I., Anton, A., Monyer, H., Urbanski, M.J., Szabo, B., Analysis of the effects of cannabinoids on identified synaptic connections in the caudate-putamen by paired recordings in transgenic mice. J. Physiol. 575 (2006), 789–806.
55. Freund, T.F., Katona, I., Piomelli, D., Role of endogenous cannabinoids in synaptic signaling. Physiol. Rev. 83 (2003), 1017–1066.
56. Garber, K.B., Visootsak, J., Warren, S.T., Fragile X syndrome. Eur. J. Hum. Genet. 16 (2008), 666–672.
57. George, O., Koob, G.F., Individual differences in prefrontal cortex function and the transition from drug use to drug dependence. Neurosci. Biobehav Rev. 35 (2010), 232–247.
58. Gerdeman, G., Lovinger, D.M., CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum. J. Neurophysiol. 85 (2001), 468–471.
59. Gerdeman, G.L., Lovinger, D.M., Emerging roles for endocannabinoids in long-term synaptic plasticity. Br. J. Pharmacol. 140 (2003), 781–789.
60. Gerdeman, G.L., Ronesi, J., Lovinger, D.M., Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. Nat. Neurosci. 5 (2002), 446–451.
61. Goldman-Rakic, P.S., Cellular and circuit basis of working memory in prefrontal cortex of nonhuman primates. Prog. Brain Res. 85 (1990), 325–335.
62. Goldstein, R.Z., Volkow, N.D., Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nat. Rev. Neurosci. 12 (2011), 652–669.
63. Gomez-Gonzalo, M., Navarrete, M., Perea, G., Covelo, A., Martin-Fernandez, M., Shigemoto, R., Lujan, R., Araque, A., Endocannabinoids induce lateral long-term potentiation of transmitter release by stimulation of gliotransmission. Cereb. Cortex 25 (2015), 3699–3712.
64. Goto, Y., Yang, C.R., Otani, S., Functional and dysfunctional synaptic plasticity in prefrontal cortex: roles in psychiatric disorders. Biol. Psychiatry 67 (2010), 199–207.
65. Gremel, C.M., Chancey, J.H., Atwood, B.K., Luo, G., Neve, R., Ramakrishnan, C., Deisseroth, K., Lovinger, D.M., Costa, R.M., Endocannabinoid modulation of orbitostriatal circuits gates habit formation. Neuron 90 (2016), 1312–1324.
66. Grueter, B.A., Brasnjo, G., Malenka, R.C., Postsynaptic TRPV1 triggers cell type-specific long-term depression in the nucleus accumbens. Nat. Neurosci. 13 (2010), 1519–1525.
67. Han, J., Kesner, P., Metna-Laurent, M., Duan, T., Xu, L., Georges, F., Koehl, M., Abrous, D.N., Mendizabal-Zubiaga, J., Grandes, P., Liu, Q., Bai, G., Wang, W., Xiong, L., Ren, W., Marsicano, G., Zhang, X., Acute cannabinoids impair working memory through astroglial CB1 receptor modulation of hippocampal LTD. Cell 148 (2012), 1039–1050.
68. Hansson, A.C., Bermudez-Silva, F.J., Malinen, H., Hyytia, P., Sanchez-Vera, I., Rimondini, R., Rodriguez de Fonseca, F., Kunos, G., Sommer, W.H., Heilig, M., Genetic impairment of frontocortical endocannabinoid degradation and high alcohol preference. Neuropsychopharmacology 32 (2007), 117–126.
69. Hebert-Chatelain, E., Desprez, T., Serrat, R., Bellocchio, L., Soria-Gomez, E., Busquets-Garcia, A., Pagano Zottola, A.C., Delamarre, A., Cannich, A., Vincent, P., Varilh, M., Robin, L.M., Terral, G., Garcia-Fernandez, M.D., Colavita, M., Mazier, W., Drago, F., Puente, N., Reguero, L., Elezgarai, I., Dupuy, J.W., Cota, D., Lopez-Rodriguez, M.L., Barreda-Gomez, G., Massa, F., Grandes, P., Benard, G., Marsicano, G., A cannabinoid link between mitochondria and memory. Nature 539 (2016), 555–559.
70. Heifets, B.D., Castillo, P.E., Endocannabinoid signaling and long-term synaptic plasticity. Annu. Rev. Physiol. 71 (2009), 283–306.
71. Heng, L., Beverley, J.A., Steiner, H., Tseng, K.Y., Differential developmental trajectories for CB1 cannabinoid receptor expression in limbic/associative and sensorimotor cortical areas. Synapse 65 (2011), 278–286.
72. Hilario, M.R., Clouse, E., Yin, H.H., Costa, R.M., Endocannabinoid signaling is critical for habit formation. Front. Integr. Neurosci., 1, 2007, 6.
73. Hilario, M.R., Costa, R.M., High on habits. Front. Neurosci. 2 (2008), 208–217.
74. Hill, M.N., McLaughlin, R.J., Pan, B., Fitzgerald, M.L., Roberts, C.J., Lee, T.T., Karatsoreos, I.N., Mackie, K., Viau, V., Pickel, V.M., McEwen, B.S., Liu, Q.S., Gorzalka, B.B., Hillard, C.J., Recruitment of prefrontal cortical endocannabinoid signaling by glucocorticoids contributes to termination of the stress response. J. Neurosci. 31 (2011), 10506–10515.
75. Hillard, C.J., Weinlander, K.M., Stuhr, K.L., Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence. Neuroscience 204 (2012), 207–229.
76. Hirvonen, J., Zanotti-Fregonara, P., Umhau, J.C., George, D.T., Rallis-Frutos, D., Lyoo, C.H., Li, C.T., Hines, C.S., Sun, H., Terry, G.E., Morse, C., Zoghbi, S.S., Pike, V.W., Innis, R.B., Heilig, M., Reduced cannabinoid CB1 receptor binding in alcohol dependence measured with positron emission tomography. Mol. Psychiatry 18 (2013), 916–921.
77. Ho, W.S., Barrett, D.A., Randall, M.D., 'Entourage' effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors. Br. J. Pharmacol. 155 (2008), 837–846.
78. Hoffman, A.F., Oz, M., Caulder, T., Lupica, C.R., Functional tolerance and blockade of long-term depression at synapses in the nucleus accumbens after chronic cannabinoid exposure. J. Neurosci. 23 (2003), 4815–4820.
79. Hohmann, A.G., Herkenham, M., Localization of cannabinoid CB(1) receptor mRNA in neuronal subpopulations of rat striatum: a double-label in situ hybridization study. Synapse 37 (2000), 71–80.
80. Hurd, Y.L., Michaelides, M., Miller, M.L., Jutras-Aswad, D., Trajectory of adolescent cannabis use on addiction vulnerability. Neuropharmacol 76:Pt B (2014), 416–424.
81. Imperatore, R., Morello, G., Luongo, L., Taschler, U., Romano, R., De Gregorio, D., Belardo, C., Maione, S., Di Marzo, V., Cristino, L., Genetic deletion of monoacylglycerol lipase leads to impaired cannabinoid receptor CB1 R signaling and anxiety-like behavior. J. Neurochem. 135 (2015), 799–813.
82. Jung, K.M., Sepers, M., Henstridge, C.M., Lassalle, O., Neuhofer, D., Martin, H., Ginger, M., Frick, A., DiPatrizio, N.V., Mackie, K., Katona, I., Piomelli, D., Manzoni, O.J., Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome. Nat. Commun., 3, 2012, 1080.
83. Kano, M., Ohno-Shosaku, T., Hashimotodani, Y., Uchigashima, M., Watanabe, M., Endocannabinoid-mediated control of synaptic transmission. Physiol. Rev. 89 (2009), 309–380.
84. Kasanetz, F., Lafourcade, M., Deroche-Gamonet, V., Revest, J.M., Berson, N., Balado, E., Fiancette, J.F., Renault, P., Piazza, P.V., Manzoni, O.J., Prefrontal synaptic markers of cocaine addiction-like behavior in rats. Mol. Psychiatry 18 (2013), 729–737.
85. Katona, I., Freund, T.F., Multiple functions of endocannabinoid signaling in the brain. Annu. Rev. Neurosci. 35 (2012), 529–558.
86. Katona, I., Urban, G.M., Wallace, M., Ledent, C., Jung, K.M., Piomelli, D., Mackie, K., Freund, T.F., Molecular composition of the endocannabinoid system at glutamatergic synapses. J. Neurosci. 26 (2006), 5628–5637.
87. Koralek, J.D., Meier, D., Hinton, J.P., Bauer, A., Parameswaran, S.A., Vishwanath, A., Ramesh, R., Schoenlein, R.W., Pfleiderer, C., Orenstein, J., Observation of coherent helimagnons and gilbert damping in an itinerant magnet. Phys. Rev. Lett., 109, 2012, 247204.
88. Kravitz, A.V., Freeze, B.S., Parker, P.R., Kay, K., Thwin, M.T., Deisseroth, K., Kreitzer, A.C., Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry. Nature 466 (2010), 622–626.
89. Kravitz, A.V., Tye, L.D., Kreitzer, A.C., Distinct roles for direct and indirect pathway striatal neurons in reinforcement. Nat. Neurosci. 15 (2012), 816–818.
90. Kreitzer, A.C., Malenka, R.C., Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models. Nature 445 (2007), 643–647.
91. Kubota, Y., Kawaguchi, Y., Dependence of GABAergic synaptic areas on the interneuron type and target size. J. Neurosci. 20 (2000), 375–386.
92. Lafourcade, M., Elezgarai, I., Mato, S., Bakiri, Y., Grandes, P., Manzoni, O.J., Molecular components and functions of the endocannabinoid system in mouse prefrontal cortex. PLoS One, 2, 2007, e709.
93. Lafourcade, M., Larrieu, T., Mato, S., Duffaud, A., Sepers, M., Matias, I., De Smedt-Peyrusse, V., Labrousse, V.F., Bretillon, L., Matute, C., Rodriguez-Puertas, R., Laye, S., Manzoni, O.J., Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions. Nat. Neurosci. 14 (2011), 345–350.
94. Lee, T.T., Hill, M.N., Age of stress exposure modulates the immediate and sustained effects of repeated stress on corticolimbic cannabinoid CB(1) receptor binding in male rats. Neuroscience 249 (2013), 106–114.
95. Letzkus, J.J., Wolff, S.B., Luthi, A., Disinhibition, a circuit mechanism for associative learning and memory. Neuron 88 (2015), 264–276.
96. Lin, H.C., Mao, S.C., Su, C.L., Gean, P.W., The role of prefrontal cortex CB1 receptors in the modulation of fear memory. Cereb. Cortex 19 (2009), 165–175.
97. Long, L.E., Lind, J., Webster, M., Weickert, C.S., Developmental trajectory of the endocannabinoid system in human dorsolateral prefrontal cortex. BMC Neurosci., 13, 2012.
98. Lovelace, J.W., Corches, A., Vieira, P.A., Hiroto, A.S., Mackie, K., Korzus, E., An animal model of female adolescent cannabinoid exposure elicits a long-lasting deficit in presynaptic long-term plasticity. Neuropharmacology 99 (2015), 242–255.
99. Lovelace, J.W., Vieira, P.A., Corches, A., Mackie, K., Korzus, E., Impaired fear memory specificity associated with deficient endocannabinoid-dependent long-term plasticity. Neuropsychopharmacology 39 (2014), 1685–1693.
100. Lovinger, D.M., Mathur, B.N., Endocannabinoids in striatal plasticity. Park. Relat. Disord. 18:Suppl. 1 (2012), S132–S134.
101. Lutz, B., Marsicano, G., Maldonado, R., Hillard, C.J., The endocannabinoid system in guarding against fear, anxiety and stress. Nat. Rev. Neurosci. 16 (2015), 705–718.
102. Lysenko, L.V., Kim, J., Henry, C., Tyrtyshnaia, A., Kohnz, R.A., Madamba, F., Simon, G.M., Kleschevnikova, N.E., Nomura, D.K., Ezekowitz, R.A., Kleschevnikov, A.M., Monoacylglycerol lipase inhibitor JZL184 improves behavior and neural properties in Ts65Dn mice, a model of down syndrome. PLoS One, 9, 2014, e114521.
103. Maglio, L.E., Noriega-Prieto, J.A., Maraver, M.J., Fernandez de Sevilla, D., Endocannabinoid-dependent long-term potentiation of synaptic transmission at rat barrel cortex. Cereb. Cortex, 2017, 1–14.
104. Manduca, A., Lassalle, O., Sepers, M., Campolongo, P., Cuomo, V., Marsicano, G., Kieffer, B., Vanderschuren, L.J., Trezza, V., Manzoni, O.J., Interacting cannabinoid and opioid receptors in the nucleus accumbens core control adolescent social play. Front. Behav. Neurosci., 10, 2016, 211.
105. Manzoni, O.J., Bockaert, J., Cannabinoids inhibit GABAergic synaptic transmission in mice nucleus accumbens. Eur. J. Pharmacol. 412 (2001), R3–R5.
106. Maroso, M., Szabo, G.G., Kim, H.K., Alexander, A., Bui, A.D., Lee, S.H., Lutz, B., Soltesz, I., Cannabinoid control of learning and memory through HCN. Channels. Neuron 89 (2016), 1059–1073.
107. Marrs, W.R., Blankman, J.L., Horne, E.A., Thomazeau, A., Lin, Y.H., Coy, J., Bodor, A.L., Muccioli, G.G., Hu, S.S., Woodruff, G., Fung, S., Lafourcade, M., Alexander, J.P., Long, J.Z., Li, W., Xu, C., Moller, T., Mackie, K., Manzoni, O.J., Cravatt, B.F., Stella, N., The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors. Nat. Neurosci. 13 (2010), 951–957.
108. Martin, A.B., Fernandez-Espejo, E., Ferrer, B., Gorriti, M.A., Bilbao, A., Navarro, M., Rodriguez de Fonseca, F., Moratalla, R., Expression and function of CB1 receptor in the rat striatum: localization and effects on D1 and D2 dopamine receptor-mediated motor behaviors. Neuropsychopharmacology 33 (2008), 1667–1679.
109. Martin, H.G., Lassalle, O., Manzoni, O.J., Differential adulthood onset mGlu5 signaling saves prefrontal function in the fragile X mouse. Cereb. Cortex, 2016, Oct 23 [Epub ahead of print].
110. Martin, R., Bajo-Graneras, R., Moratalla, R., Perea, G., Araque, A., Circuit-specific signaling in astrocyte-neuron networks in basal ganglia pathways. Science 349 (2015), 730–734.
111. Mathur, B.N., Lovinger, D.M., Endocannabinoid-dopamine interactions in striatal synaptic plasticity. Front. Pharmacol., 3, 2012, 66.
112. Mato, S., Chevaleyre, V., Robbe, D., Pazos, A., Castillo, P.E., Manzoni, O.J., A single in-vivo exposure to delta 9THC blocks endocannabinoid-mediated synaptic plasticity. Nat. Neurosci. 7 (2004), 585–586.
113. Mato, S., Robbe, D., Puente, N., Grandes, P., Manzoni, O.J., Presynaptic homeostatic plasticity rescues long-term depression after chronic Delta 9-tetrahydrocannabinol exposure. J. Neurosci. 25 (2005), 11619–11627.
114. Matyas, F., Watanabe, M., Mackie, K., Katona, I., Freund, T.F., Molecular architecture of the cannabinoid signaling system in the core of the nucleus accumbens. Ideggyogy Sz. 60 (2007), 187–191.
115. McCutcheon, J.E., Loweth, J.A., Ford, K.A., Marinelli, M., Wolf, M.E., Tseng, K.Y., Group I mGluR activation reverses cocaine-induced accumulation of calcium-permeable AMPA receptors in nucleus accumbens synapses via a protein kinase C-dependent mechanism. J. Neurosci. 31 (2011), 14536–14541.
116. McCutcheon, J.E., Wang, X., Tseng, K.Y., Wolf, M.E., Marinelli, M., Calcium-permeable AMPA receptors are present in nucleus accumbens synapses after prolonged withdrawal from cocaine self-administration but not experimenter-administered cocaine. J. Neurosci. 31 (2011), 5737–5743.
117. McEwen, B.S., Bowles, N.P., Gray, J.D., Hill, M.N., Hunter, R.G., Karatsoreos, I.N., Nasca, C., Mechanisms of stress in the brain. Nat. Neurosci. 18 (2015), 1353–1363.
118. Mechoulam, R., Parker, L.A., The endocannabinoid system and the brain. Annu. Rev. Psychol. 64 (2013), 21–47.
119. Metna-Laurent, M., Marsicano, G., Rising stars: modulation of brain functions by astroglial type-1 cannabinoid receptors. Glia 63 (2015), 353–364.
120. Min, R., Nevian, T., Astrocyte signaling controls spike timing-dependent depression at neocortical synapses. Nat. Neurosci. 15 (2012), 746–753.
121. Navarrete, M., Araque, A., Endocannabinoids mediate neuron-astrocyte communication. Neuron 57 (2008), 883–893.
122. Navarrete, M., Araque, A., Endocannabinoids potentiate synaptic transmission through stimulation of astrocytes. Neuron 68 (2010), 113–126.
123. Navarrete, M., Diez, A., Araque, A., Astrocytes in endocannabinoid signalling. Philos. Trans. R. Soc. Lond B Biol. Sci., 369, 2014, 20130599.
124. Navarrete, M., Perea, G., Maglio, L., Pastor, J., Garcia de Sola, R., Araque, A., Astrocyte calcium signal and gliotransmission in human brain tissue. Cereb. Cortex 23 (2013), 1240–1246.
125. Nazzaro, C., Greco, B., Cerovic, M., Baxter, P., Rubino, T., Trusel, M., Parolaro, D., Tkatch, T., Benfenati, F., Pedarzani, P., Tonini, R., SK channel modulation rescues striatal plasticity and control over habit in cannabinoid tolerance. Nat. Neurosci. 15:2 (2012), 284–293.
126. Njoo, C., Agarwal, N., Lutz, B., Kuner, R., The cannabinoid receptor CB1 interacts with the WAVE1 complex and plays a role in actin dynamics and structural plasticity in neurons. PLoS Biol., 13, 2015, e1002286.
127. Orr, A.L., Hanson, J.E., Li, D., Klotz, A., Wright, S., Schenk, D., Seubert, P., Madison, D.V., beta-Amyloid inhibits E-S potentiation through suppression of cannabinoid receptor 1-dependent synaptic disinhibition. Neuron 82 (2014), 1334–1345.
128. Paille, V., Fino, E., Du, K., Morera-Herreras, T., Perez, S., Kotaleski, J.H., Venance, L., GABAergic circuits control spike-timing-dependent plasticity. J. Neurosci. 33 (2013), 9353–9363.
129. Parri, H.R., Gould, T.M., Crunelli, V., Spontaneous astrocytic Ca2+ oscillations in situ drive NMDAR-mediated neuronal excitation. Nat. Neurosci. 4 (2001), 803–812.
130. Parsons, L.H., Hurd, Y.L., Endocannabinoid signalling in reward and addiction. Nat. Rev. Neurosci. 16 (2015), 579–594.
131. Patel, S., Roelke, C.T., Rademacher, D.J., Hillard, C.J., Inhibition of restraint stress-induced neural and behavioural activation by endogenous cannabinoid signalling. Eur. J. Neurosci. 21 (2005), 1057–1069.
132. Perea, G., Araque, A., Properties of synaptically evoked astrocyte calcium signal reveal synaptic information processing by astrocytes. J. Neurosci. 25 (2005), 2192–2203.
133. Perea, G., Navarrete, M., Araque, A., Tripartite synapses: astrocytes process and control synaptic information. Trends Neurosci. 32 (2009), 421–431.
134. Peterfi, Z., Urban, G.M., Papp, O.I., Nemeth, B., Monyer, H., Szabo, G., Erdelyi, F., Mackie, K., Freund, T.F., Hajos, N., Katona, I., Endocannabinoid-mediated long-term depression of afferent excitatory synapses in hippocampal pyramidal cells and GABAergic interneurons. J. Neurosci. 32 (2012), 14448–14463.
135. Piomelli, D., The molecular logic of endocannabinoid signalling. Nat. Rev. Neurosci. 4 (2003), 873–884.
136. Puente, N., Cui, Y., Lassalle, O., Lafourcade, M., Georges, F., Venance, L., Grandes, P., Manzoni, O.J., Polymodal activation of the endocannabinoid system in the extended amygdala. Nat. Neurosci. 14 (2011), 1542–1547.
137. Rademacher, D.J., Meier, S.E., Shi, L., Ho, W.S., Jarrahian, A., Hillard, C.J., Effects of acute and repeated restraint stress on endocannabinoid content in the amygdala, ventral striatum, and medial prefrontal cortex in mice. Neuropharmacology 54 (2008), 108–116.
138. Raver, S.M., Haughwout, S.P., Keller, A., Adolescent cannabinoid exposure permanently suppresses cortical oscillations in adult mice. Neuropsychopharmacology 38 (2013), 2338–2347.
139. Realini, N., Vigano, D., Guidali, C., Zamberletti, E., Rubino, T., Parolaro, D., Chronic URB597 treatment at adulthood reverted most depressive-like symptoms induced by adolescent exposure to THC in female rats. Neuropharmacology 60 (2011), 235–243.
140. Robbe, D., Alonso, G., Duchamp, F., Bockaert, J., Manzoni, O.J., Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens. J. Neurosci. 21 (2001), 109–116.
141. Robbe, D., Kopf, M., Remaury, A., Bockaert, J., Manzoni, O.J., Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens. Proc. Natl. Acad. Sci. U.S.A 99 (2002), 8384–8388.
142. Roland, A.B., Ricobaraza, A., Carrel, D., Jordan, B.M., Rico, F., Simon, A., Humbert-Claude, M., Ferrier, J., McFadden, M.H., Scheuring, S., Lenkei, Z., Cannabinoid-induced actomyosin contractility shapes neuronal morphology and growth. Elife, 3, 2014, e03159.
143. Ronesi, J., Lovinger, D.M., Induction of striatal long-term synaptic depression by moderate frequency activation of cortical afferents in rat. J. Physiol. 562 (2005), 245–256.
144. Rouach, N., Nicoll, R.A., Endocannabinoids contribute to short-term but not long-term mGluR-induced depression in the hippocampus. Eur. J. Neurosci. 18 (2003), 1017–1020.
145. Rubino, T., Realini, N., Castiglioni, C., Guidali, C., Vigano, D., Marras, E., Petrosino, S., Perletti, G., Maccarrone, M., Di Marzo, V., Parolaro, D., Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex. Cereb. Cortex 18 (2008), 1292–1301.
146. Schneider, M., Koch, M., Chronic pubertal, but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory, and the performance in a progressive ratio task in adult rats. Neuropsychopharmacology 28 (2003), 1760–1769.
147. Scofield, M.D., Heinsbroek, J.A., Gipson, C.D., Kupchik, Y.M., Spencer, S., Smith, A.C., Roberts-Wolfe, D., Kalivas, P.W., The nucleus accumbens: mechanisms of addiction across drug classes reflect the importance of glutamate homeostasis. Pharmacol. Rev. 68 (2016), 816–871.
148. Seamans, J.K., Floresco, S.B., Phillips, A.G., Functional differences between the prelimbic and anterior cingulate regions of the rat prefrontal cortex. Behav. Neurosci. 109 (1995), 1063–1073.
149. Sesack, S.R., Grace, A.A., Cortico-Basal Ganglia reward network: microcircuitry. Neuropsychopharmacology 35 (2010), 27–47.
150. Shen, W., Flajolet, M., Greengard, P., Surmeier, D.J., Dichotomous dopaminergic control of striatal synaptic plasticity. Science 321 (2008), 848–851.
151. Shen, W., Plotkin, J.L., Francardo, V., Ko, W.K., Xie, Z., Li, Q., Fieblinger, T., Wess, J., Neubig, R.R., Lindsley, C.W., Conn, P.J., Greengard, P., Bezard, E., Cenci, M.A., Surmeier, D.J., M4 muscarinic receptor signaling ameliorates striatal plasticity deficits in models of L-DOPA-induced dyskinesia. Neuron 88 (2015), 762–773.
152. Smith, R.J., Lobo, M.K., Spencer, S., Kalivas, P.W., Cocaine-induced adaptations in D1 and D2 accumbens projection neurons (a dichotomy not necessarily synonymous with direct and indirect pathways). Curr. Opin. Neurobiol. 23 (2013), 546–552.
153. Speed, H.E., Masiulis, I., Gibson, J.R., Powell, C.M., Increased cortical inhibition in autism-linked Neuroligin-3R451C mice is due in part to loss of endocannabinoid signaling. PLoS One, 10, 2015, e0140638.
154. Stempel, A.V., Stumpf, A., Zhang, H.Y., Ozdogan, T., Pannasch, U., Theis, A.K., Otte, D.M., Wojtalla, A., Racz, I., Ponomarenko, A., Xi, Z.X., Zimmer, A., Schmitz, D., Cannabinoid type 2 receptors mediate a cell type-specific plasticity in the Hippocampus. Neuron 90 (2016), 795–809.
155. Tang, A.H., Alger, B.E., Homer protein-metabotropic glutamate receptor binding regulates endocannabinoid signaling and affects hyperexcitability in a mouse model of fragile X syndrome. J. Neurosci. 35 (2015), 3938–3945.
156. Tanimura, A., Yamazaki, M., Hashimotodani, Y., Uchigashima, M., Kawata, S., Abe, M., Kita, Y., Hashimoto, K., Shimizu, T., Watanabe, M., Sakimura, K., Kano, M., The endocannabinoid 2-arachidonoylglycerol produced by diacylglycerol lipase alpha mediates retrograde suppression of synaptic transmission. Neuron 65 (2010), 320–327.
157. Tecuapetla, F., Jin, X., Lima, S.Q., Costa, R.M., Complementary contributions of striatal projection pathways to action initiation and execution. Cell 166 (2016), 703–715.
158. Thomazeau, A., Lassalle, O., Iafrati, J., Souchet, B., Guedj, F., Janel, N., Chavis, P., Delabar, J., Manzoni, O.J., Prefrontal deficits in a murine model overexpressing the down syndrome candidate gene dyrk1a. J. Neurosci. 34 (2014), 1138–1147.
159. Trusel, M., Cavaccini, A., Gritti, M., Greco, B., Saintot, P.P., Nazzaro, C., Cerovic, M., Morella, I., Brambilla, R., Tonini, R., Coordinated regulation of synaptic plasticity at striatopallidal and striatonigral neurons orchestrates motor control. Cell Rep. 13 (2015), 1353–1365.
160. Uchigashima, M., Narushima, M., Fukaya, M., Katona, I., Kano, M., Watanabe, M., Subcellular arrangement of molecules for 2-arachidonoyl-glycerol-mediated retrograde signaling and its physiological contribution to synaptic modulation in the striatum. J. Neurosci. 27 (2007), 3663–3676.
161. Uchigashima, M., Yamazaki, M., Yamasaki, M., Tanimura, A., Sakimura, K., Kano, M., Watanabe, M., Molecular and morphological configuration for 2-arachidonoylglycerol-mediated retrograde signaling at mossy cell-granule cell synapses in the dentate gyrus. J. Neurosci. 31 (2011), 7700–7714.
162. Van Waes, V., Beverley, J.A., Siman, H., Tseng, K.Y., Steiner, H., CB1 cannabinoid receptor expression in the striatum: association with corticostriatal circuits and developmental regulation. Front. Pharmacol., 3, 2012, 21.
163. Vicente, A.M., Galvao-Ferreira, P., Tecuapetla, F., Costa, R.M., Direct and indirect dorsolateral striatum pathways reinforce different action strategies. Curr. Biol. 26 (2016), R267–R269.
164. Viganò, D., Valenti, M., Cascio, M.G., Di Marzo, V., Parolaro, D., Rubino, T., Changes in endocannabinoid levels in a rat model of behavioural sensitization to morphine. Eur. J. Neurosci. 20 (2004), 1849–1857.
165. Vinod, K.Y., Yalamanchili, R., Xie, S., Cooper, T.B., Hungund, B.L., Effect of chronic ethanol exposure and its withdrawal on the endocannabinoid system. Neurochem. Int. 49 (2006), 619–625.
166. Volkow, N.D., Hampson, A.J., Baler, R.D., Don't worry, Be happy: endocannabinoids and cannabis at the intersection of stress and reward. Annu. Rev. Pharmacol. Toxicol. 57 (2017), 285–308.
167. Wang, W., Trieu, B.H., Palmer, L.C., Jia, Y., Pham, D.T., Jung, K.M., Karsten, C.A., Merrill, C.B., Mackie, K., Gall, C.M., Piomelli, D., Lynch, G., A primary cortical input to Hippocampus expresses a pathway-specific and endocannabinoid-dependent form of long-term potentiation. eNeuro, 3, 2016.
168. Wang, Z., Kai, L., Day, M., Ronesi, J., Yin, H.H., Ding, J., Tkatch, T., Lovinger, D.M., Surmeier, D.J., Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons. Neuron 50 (2006), 443–452.
169. Watanabe, S., Doshi, M., Hamazaki, T., n-3 Polyunsaturated fatty acid (PUFA) deficiency elevates and n-3 PUFA enrichment reduces brain 2-arachidonoylglycerol level in mice. Prostagl. Leukot. Essent. Fat. Acids 69 (2003), 51–59.
170. Willsey, A.J., Sanders, S.J., Li, M., Dong, S., Tebbenkamp, A.T., Muhle, R.A., Reilly, S.K., Lin, L., Fertuzinhos, S., Miller, J.A., Murtha, M.T., Bichsel, C., Niu, W., Cotney, J., Ercan-Sencicek, A.G., Gockley, J., Gupta, A.R., Han, W., He, X., Hoffman, E.J., Klei, L., Lei, J., Liu, W., Liu, L., Lu, C., Xu, X., Zhu, Y., Mane, S.M., Lein, E.S., Wei, L., Noonan, J.P., Roeder, K., Devlin, B., Sestan, N., State, M.W., Coexpression networks implicate human midfetal deep cortical projection neurons in the pathogenesis of autism. Cell 155 (2013), 997–1007.
171. Wilson, C.J., GABAergic inhibition in the neostriatum. Prog. Brain Res. 160 (2007), 91–110.
172. Wilson, R.I., Nicoll, R.A., Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 410 (2001), 588–592.
173. Winters, B.D., Kruger, J.M., Huang, X., Gallaher, Z.R., Ishikawa, M., Czaja, K., Krueger, J.M., Huang, Y.H., Schluter, O.M., Dong, Y., Cannabinoid receptor 1-expressing neurons in the nucleus accumbens. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), E2717–E2725.
174. Wu, Y.W., Kim, J.I., Tawfik, V.L., Lalchandani, R.R., Scherrer, G., Ding, J.B., Input- and cell-type-specific endocannabinoid-dependent LTD in the striatum. Cell Rep. 10 (2015), 75–87.
175. Xi, Z.X., Peng, X.Q., Li, X., Song, R., Zhang, H.Y., Liu, Q.R., Yang, H.J., Bi, G.H., Li, J., Gardner, E.L., Brain cannabinoid CB(2) receptors modulate cocaine's actions in mice. Nat. Neurosci. 14 (2011), 1160–1166.
176. Xu, J., Antion, M.D., Nomura, T., Kraniotis, S., Zhu, Y., Contractor, A., Hippocampal metaplasticity is required for the formation of temporal associative memories. J. Neurosci. 34 (2014), 16762–16773.
177. Xu, J.Y., Zhang, J., Chen, C., Long-lasting potentiation of hippocampal synaptic transmission by direct cortical input is mediated via endocannabinoids. J. Physiol. 590:10 (2012), 2305–2315.
178. Yin, H.H., Davis, M.I., Ronesi, J.A., Lovinger, D.M., The role of protein synthesis in striatal long-term depression. J. Neurosci. 26 (2006), 11811–11820.
179. Yin, H.H., Lovinger, D.M., Frequency-specific and D2 receptor-mediated inhibition of glutamate release by retrograde endocannabinoid signaling. Proc. Natl. Acad. Sci. U. S. A. 103 (2006), 8251–8256.
180. Yin, H.H., Mulcare, S.P., Hilario, M.R., Clouse, E., Holloway, T., Davis, M.I., Hansson, A.C., Lovinger, D.M., Costa, R.M., Dynamic reorganization of striatal circuits during the acquisition and consolidation of a skill. Nat. Neurosci. 12 (2009), 333–341.
181. Yoshino, H., Miyamae, T., Hansen, G., Zambrowicz, B., Flynn, M., Pedicord, D., Blat, Y., Westphal, R.S., Zaczek, R., Lewis, D.A., Gonzalez-Burgos, G., Postsynaptic diacylglycerol lipase mediates retrograde endocannabinoid suppression of inhibition in mouse prefrontal cortex. J. Physiol. 589 (2011), 4857–4884.
182. Younts, T.J., Castillo, P.E., Endogenous cannabinoid signaling at inhibitory interneurons. Curr. Opin. Neurobiol. 26 (2014), 42–50.
183. Younts, T.J., Chevaleyre, V., Castillo, P.E., CA1 pyramidal cell theta-burst firing triggers endocannabinoid-mediated long-term depression at both somatic and dendritic inhibitory synapses. J. Neurosci. 33 (2013), 13743–13757.
184. Younts, T.J., Monday, H.R., Dudok, B., Klein, M.E., Jordan, B.A., Katona, I., Castillo, P.E., Presynaptic protein synthesis is required for long-term plasticity of GABA release. Neuron 92 (2016), 479–492.
185. Zhang, L., Alger, B.E., Enhanced endocannabinoid signaling elevates neuronal excitability in fragile X syndrome. J. Neurosci. 30 (2010), 5724–5729.